The Rise of Mega Rounds in Biotech Investment Panel – Global Biopharma Leadership Forum 2025

This panel, organized by MSQ Ventures, featured our SVP & Managing Director, Naveen Krishnan, alongside prominent investors, operators, and advisors and explored why securing why securing mega-round financing has become increasingly difficult amid macroeconomic uncertainty and valuation pressures. Click here for more details.